Valued at $180.0M at its later-stage round, Jan 2025. Nothing has traded since.
- ·Watch ZetaGen Therapeutics: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
ZetaGen Therapeutics funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jan 2025 | Early Stage VC | $12.9M | ▮ | ▮ |
| Apr 2022 | Early Stage VC | $9.6M | ▮ | ▮ |
| Dec 2019 | Seed Round | $840K | ▮ | ▮ |
| Jul 2018 | Debt | $1.0M | ▮ | ▮ |
Membership and data by Private Market View
ZetaGen Therapeutics valuation
ZetaGen Therapeutics was valued at $180 million at its later-stage round in Jan 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has ZetaGen Therapeutics raised?
ZetaGen Therapeutics has raised $52.5 million in total; 4 of its rounds are on record, from 2018 on. The largest on record was a $9.6 million early-stage round in Apr 2022; the most recent was a $12.9 million early-stage round in Jan 2025.
ZetaGen Therapeutics has filed 5 Form Ds with the SEC since 2018, most recently in Nov 2025 ($12.9 million sold to 35 investors).
How ZetaGen Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For ZetaGen Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about ZetaGen Therapeutics
- What is ZetaGen Therapeutics worth?
- ZetaGen Therapeutics is valued at $180.0M as of Oct 2026. Valued at $180.0M at its later-stage round, Jan 2025. Nothing has traded since.
- How much has ZetaGen Therapeutics raised?
- ZetaGen Therapeutics has raised $52.5M in total funding across 4 recorded rounds.
- When did ZetaGen Therapeutics last raise?
- ZetaGen Therapeutics last raised in Jan 2025 (Early Stage VC), raising $12.9M.